wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37632167-49582375-BCB6-4D3E-AEC3-CB5E78A3B66D
Q37632167-49582375-BCB6-4D3E-AEC3-CB5E78A3B66D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37632167-49582375-BCB6-4D3E-AEC3-CB5E78A3B66D
Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies.
P2860
Q37632167-49582375-BCB6-4D3E-AEC3-CB5E78A3B66D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37632167-49582375-BCB6-4D3E-AEC3-CB5E78A3B66D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4cabfd9f4cc87782c61f568201be004e1254db2
P2860
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.